Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment

被引：0
|
作者：
Wei, T. [1 ]
Wang, D. [2 ]
Peng, Y. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Breast Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294P
引用
收藏
页码：S301 / S302
页数：2
相关论文
共 50 条
  • [1] Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    Altundag, Kadri
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (02) : 328 - 328
  • [2] Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
    Paralta Branco, F.
    Silva, F.
    Andre, S.
    Catarino, A.
    Madureira, R.
    Moreira Pinto, J.
    Godinho, J.
    Simoes, P.
    Freitas, A. C.
    Casa-Nova, M.
    Nave, M.
    Augusto, J.
    Passos-Coelho, J. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S94 - S94
  • [3] In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
    Melanie Spears
    Karen J. Taylor
    Alison F. Munro
    Carrie A. Cunningham
    Elizabeth A. Mallon
    Chris J. Twelves
    David A. Cameron
    Jeremy Thomas
    John M. S. Bartlett
    [J]. Breast Cancer Research and Treatment, 2012, 132 : 463 - 470
  • [4] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, Sora
    Lee, So Heun
    Lee, Hee Jin
    Jeong, Hyehyun
    Jeong, Jae Ho
    Kim, Jeong Eun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Gong, Gyungyub
    Kim, Hak Hee
    Lee, Saebyeol
    Lee, Jongwon
    Kim, Sung-Bae
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [5] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, S.
    Lee, S. H.
    Lee, H. J.
    Jeong, H.
    Jeong, J-H.
    Kim, J. E.
    Ahn, J-H.
    Jung, K. H.
    Kim, H. H.
    Lee, S.
    Lee, J.
    Kim, S-B.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S305 - S305
  • [6] Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
    Kutlu, Yasin
    Cekin, Ruhper
    Aydin, Sabin Goktas
    Shbair, Abdallah T. M.
    Bilici, Ahmet
    Arici, Serdar
    Oven, Bala Basak
    Acikgoz, Ozgur
    Ozcan, Erkan
    Olmez, Omer Fatih
    Cakir, Asli
    Seker, Mesut
    [J]. CURRENT PROBLEMS IN CANCER, 2024, 50
  • [7] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [8] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [9] In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer
    Spears, Melanie
    Taylor, Karen J.
    Munro, Alison F.
    Cunningham, Carrie A.
    Mallon, Elizabeth A.
    Twelves, Chris J.
    Cameron, David A.
    Thomas, Jeremy
    Bartlett, John M. S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 463 - 470
  • [10] Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients? Reply
    Yoshida, Atsushi
    Hayashi, Naoki
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (02) : 329 - 329
12345